Gene · 1787
Papers1,524
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,524
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Histone 4 lysine 20 tri-methylation: a key epigenetic regulator in chromatin structure and disease. | Front Genet | 2023 | 37671044 | PubTator, text mining | PubMed |
| Identification and validation of a novel prognosis model based on m5C-related long non-coding RNAs in colorectal cancer. | Cancer Cell Int | 2023 | 37670275 | PubTator, text mining | PubMed |
| Identification of m5C-related lncRNAs signature to predict prognosis and therapeutic responses in esophageal squamous cell carcinoma patients. | Sci Rep | 2023 | 37666951 | PubTator, text mining | PubMed |
| Pyrimidine metabolism regulator-mediated molecular subtypes display tumor microenvironmental hallmarks and assist precision treatment in bladder cancer. | Front Oncol | 2023 | 37664033 | PubTator, text mining | PubMed |
| Comprehensive analysis of PILRΑ's association with the prognosis, tumor immune infiltration, and immunotherapy in pan-cancer. | Sci Rep | 2023 | 37652967 | PubTator, text mining | PubMed |
| Epigenetic regulation in major depression and other stress-related disorders: molecular mechanisms, clinical relevance and therapeutic potential. | Signal Transduct Target Ther | 2023 | 37644009 | PubTator, text mining | PubMed |
| Early Prediction of Asthma. | J Clin Med | 2023 | 37629446 | PubTator, text mining | PubMed |
| Insights into the Inhibitory Mechanisms of the Covalent Drugs for DNMT3A. | Int J Mol Sci | 2023 | 37628829 | PubTator, text mining | PubMed |
| TRDMT1-mediated RNA C-5 methylation as a novel target in anticancer therapy. | Biochim Biophys Acta Rev Cancer | 2023 | 37625528 | PubTator, text mining | PubMed |
| Methylation across the central dogma in health and diseases: new therapeutic strategies. | Signal Transduct Target Ther | 2023 | 37620312 | PubTator, text mining | PubMed |
| The hidden RNA code: implications of the RNA epitranscriptome in the context of viral infections. | Front Genet | 2023 | 37614818 | PubTator, text mining | PubMed |
| RNA modification: mechanisms and therapeutic targets. | Mol Biomed | 2023 | 37612540 | PubTator, text mining | PubMed |
| Queuosine-tRNA promotes sex-dependent learning and memory formation by maintaining codon-biased translation elongation speed. | EMBO J | 2023 | 37609797 | PubTator, text mining | PubMed |
| The multi-omics analyses of acsl1 reveal its translational significance as a tumor microenvironmental and prognostic biomarker in clear cell renal cell carcinoma. | Diagn Pathol | 2023 | 37608295 | PubTator, text mining | PubMed |
| Hypermethylation of RNF125 promotes autophagy-induced oxidative stress in asthma by increasing HMGB1 stability. | iScience | 2023 | 37599832 | PubTator, text mining | PubMed |
| Restricted tRNA methylation by intermolecular disulfide bonds in DNMT2/TRDMT1. | Int J Biol Macromol | 2023 | 37579906 | PubTator, text mining | PubMed |
| Construction of a prognostic signature associated with liver metastases for prognosis and immune response prediction in colorectal cancer. | Front Oncol | 2023 | 37564935 | PubTator, text mining | PubMed |
| Reinvestigating the clinical relevance of the m6A writer METTL3 in urothelial carcinoma of the bladder. | iScience | 2023 | 37554463 | PubTator, text mining | PubMed |
| Using integrated analysis from multicentre studies to identify RNA methylation-related lncRNA risk stratification systems for glioma. | Cancer Cell Int | 2023 | 37542290 | PubTator, text mining | PubMed |
| Identification of a novel 5-methylcytosine-related signature for prognostic prediction of kidney renal papillary cell carcinoma and a Putative target for drug repurposing. | Transl Oncol | 2023 | 37523897 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1787/papers?page=8